Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9116 |
High Similarity |
NPD4584 |
Approved |
0.9097 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD7298 |
Approved |
0.8533 |
High Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD3641 |
Approved |
0.8497 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.8497 |
Intermediate Similarity |
NPD3639 |
Approved |
0.8387 |
Intermediate Similarity |
NPD4017 |
Approved |
0.8355 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8098 |
Intermediate Similarity |
NPD6107 |
Approved |
0.8072 |
Intermediate Similarity |
NPD8252 |
Approved |
0.8072 |
Intermediate Similarity |
NPD8251 |
Approved |
0.8072 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7865 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7821 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7811 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7746 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7738 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7712 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.7633 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7574 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7529 |
Intermediate Similarity |
NPD27 |
Approved |
0.7529 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD2563 |
Approved |
0.747 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7469 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7443 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7401 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7363 |
Intermediate Similarity |
NPD5582 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD3885 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4475 |
Approved |
0.733 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.733 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD3349 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD4859 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7239 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7247 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6365 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD4210 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD5754 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7191 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD3408 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7169 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD6493 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7112 |
Intermediate Similarity |
NPD5457 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7103 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2358 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD4498 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7041 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD1421 |
Approved |
0.7039 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1420 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7400 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD3763 |
Approved |
0.7019 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7607 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD2120 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7011 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7011 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7011 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5600 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5772 |
Approved |
0.6994 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD6386 |
Approved |
0.6982 |
Remote Similarity |
NPD6385 |
Approved |
0.6981 |
Remote Similarity |
NPD2653 |
Approved |
0.6957 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD2490 |
Approved |
0.6957 |
Remote Similarity |
NPD2488 |
Approved |
0.6954 |
Remote Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD3983 |
Phase 3 |
0.6952 |
Remote Similarity |
NPD7034 |
Discontinued |
0.6952 |
Remote Similarity |
NPD5564 |
Approved |
0.6946 |
Remote Similarity |
NPD2122 |
Discontinued |
0.6943 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD3145 |
Approved |
0.6943 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD5109 |
Approved |
0.6943 |
Remote Similarity |
NPD3144 |
Approved |
0.6937 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6937 |
Remote Similarity |
NPD7119 |
Phase 2 |
0.6935 |
Remote Similarity |
NPD8318 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1669 |
Approved |
0.6928
|
Remote Similarity |
NPD4123 |
Phase 3 |